Search Results 1031-1040 of 19276 for autoimmune hepatitis

  1. Rab GTPases As Drivers of Lipid Droplet Metabolism in Hepatocellular Carcinoma - Mayo Clinic Research

    Risk factors for HCC include fatty liver disease, which leads to chronic inflammation and scarring as precursors to HCC. Metabolic rewiring is a hallmark of ...

  2. Publications - Zachary S. Kelm, M.D., Ph.D. - Mayo Clinic

    ... Liver Disease and Metastases from Colorectal Cancer CT Images. J Imaging Inform Med. 2024 Oct; 37 (5):2186-2194 Epub 2024 Apr 08. View PubMed; Dhillon P ...

  3. Publications - Amer N. Kalaaji, M.D. - Mayo Clinic

    Infection and infection prevention in patients treated with immunosuppressive medications for autoimmune bullous disorders. Dermatol Clin. 2011 Oct; 29(4):591-8 ...

  4. Polycystic kidney disease - Doctors and departments - Mayo Clinic

    ... liver disease and is a potential treatment option for people who have PKD with liver involvement. These medicines are now in clinical trials, and tolvaptan ...

  5. Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung - Mayo Clinic

    hepatitis, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel ... - Patients with a history of autoimmune-related hypothyroidism who are on

  6. Ruxolitinib (topical application route) - Mayo Clinic

    May make these conditions worse. Liver disease (eg, hepatitis B or C), active or; Serious infections, active—Use is not recommended in patients with these ...

  7. End-stage renal disease - Doctors and departments - Mayo Clinic

    High blood pressure (hypertension) and chronic kidney disease; Kidney disease and chronic liver disease; Genetics behind kidney diseases; Understanding what ...

  8. Polycystic kidney disease - Doctors and departments - Mayo Clinic

    ... liver disease and is a potential treatment option for people who have PKD with liver involvement. These medicines are now in clinical trials, and tolvaptan ...

  9. Azithromycin (intravenous route) - Mayo Clinic

    Liver disease, history of—Should not be used in patients with this condition. Back to top. Proper Use.

  10. Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer - Mayo Clinic

    Subject has active, known or suspected autoimmune disease, including systemic lupus ... auto-immune hepatitis. Subjects with Type I diabetes mellitus ...